Upregulation of VDR-associated lncRNAs in Schizophrenia.
LINC00346
LINC00511
SNHG6
Schizophrenia
lncRNA
Journal
Journal of molecular neuroscience : MN
ISSN: 1559-1166
Titre abrégé: J Mol Neurosci
Pays: United States
ID NLM: 9002991
Informations de publication
Date de publication:
Feb 2022
Feb 2022
Historique:
received:
21
07
2021
accepted:
14
08
2021
pubmed:
10
9
2021
medline:
5
4
2022
entrez:
9
9
2021
Statut:
ppublish
Résumé
Vitamin D receptor (VDR) signaling has been found to contribute to the pathology of numerous neuropsychiatric diseases including schizophrenia. Notably, VDR signaling has a functional relationship with many long non-coding RNAs (lncRNAs) such as SNHG6, LINC00346 and LINC00511. We calculated expression of these lncRNAs in the venous blood of patients with schizophrenia versus healthy individuals. Expression of SNHG6 was significantly higher in cases versus controls (posterior beta = 0.552, adjusted P value < 0.0001). This pattern of expression was detected in both men (posterior beta = 0.556, adjusted P value < 0.0001) and women (posterior beta = 0.31, adjusted P value = 0.005). Expression of LINC00346 was also higher in cases versus controls (posterior beta = 0.497, adjusted P value < 0.0001) and in distinct sex-based comparisons (posterior beta = 0.451, adjusted P value = 0.009 among men and posterior beta = 0.214, P value = 0.004 among women). Expression of LINC00511 was higher in cases versus controls (posterior beta = 0.318, adjusted P value = 0.01). While sex-based comparisons revealed significant difference in expression of LINC00511 among female subgroups (posterior beta = 0.424, adjusted P value = 0.016), such comparison showed no difference among male cases and male controls (adjusted P value = 0.295). The expression levels of SNHG6 distinguished patients with schizophrenia from controls, with AUC = 0.932. LINC00346 and LINC00511 distinguished between the two groups with AUC values of 0.795 and 0.706, respectively. Therefore, these lncRNAs might be used as markers for schizophrenia.
Identifiants
pubmed: 34499334
doi: 10.1007/s12031-021-01901-y
pii: 10.1007/s12031-021-01901-y
doi:
Substances chimiques
RNA, Long Noncoding
0
Receptors, Calcitriol
0
VDR protein, human
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
239-245Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Asadzadeh Manjili F, Kalantar SM, Arsang-Jang S, Ghafouri-Fard S, Taheri M, Sayad A (2018) Upregulation of vitamin D-related genes in schizophrenic patients. Neuropsychiatr Dis Treat 14:2583–2591
doi: 10.2147/NDT.S176301
American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders. https://doi.org/10.1176/appi.books.9780890425596
Beveridge NJ, Gardiner E, Carroll A, Tooney P, Cairns M (2010) Schizophrenia is associated with an increase in cortical microRNA biogenesis. Mol Psychiatry 15:1176–1189
doi: 10.1038/mp.2009.84
Bhugra D (2005) The global prevalence of schizophrenia. PLoS Med 2:e151–e175
doi: 10.1371/journal.pmed.0020151
Bikle DD (2021) Vitamin D regulation of and by long non coding RNAs. Mol Cell Endocrinol 532 111317
Børglum AD, Demontis D, Grove J, Pallesen J, Hollegaard MV, Pedersen C, Hedemand A, Mattheisen M, Uitterlinden A, Nyegaard M (2014) Genome-wide study of association and interaction with maternal cytomegalovirus infection suggests new schizophrenia loci. Mol Psychiatry 19:325–333
doi: 10.1038/mp.2013.2
Carlberg C (2014) Genome-wide (over) view on the actions of vitamin D. Front Physiol 5:167
Chang L, Yuan Y, Li C, Guo T, Qi H, Xiao Y, Dong X, Liu Z, Liu Q (2016) Upregulation of SNHG6 regulates ZEB1 expression by competitively binding miR-101-3p and interacting with UPF1 in hepatocellular carcinoma. Cancer Lett 383:183–194
doi: 10.1016/j.canlet.2016.09.034
Cui X, Mcgrath JJ, Burne TH, Eyles DW (2021) Vitamin D and schizophrenia: 20 years on. Mol Psychiatry 1–13
Cui X, Pelekanos M, Liu P-Y, Burne T, McGrath J, Eyles D (2013) The vitamin D receptor in dopamine neurons; its presence in human substantia nigra and its ontogenesis in rat midbrain. Neuroscience 236:77–87
doi: 10.1016/j.neuroscience.2013.01.035
Cui Z, Pu T, Zhang Y, Wang J, Zhao Y (2020) Long non-coding RNA LINC00346 contributes to cisplatin resistance in nasopharyngeal carcinoma by repressing miR-342–5p. Open biol 10190286
Eyles D, Brown J, Mackay-Sim A, McGrath J, Feron F (2003) Vitamin D3 and brain development. Neuroscience 118:641–653
doi: 10.1016/S0306-4522(03)00040-X
Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ (2005) Distribution of the vitamin D receptor and 1α-hydroxylase in human brain. J Chem Neuroanat 29:21–30
doi: 10.1016/j.jchemneu.2004.08.006
Feron F, Burne T, Brown J, Smith E, McGrath J, Mackay-Sim A, Eyles D (2005) Developmental Vitamin D3 deficiency alters the adult rat brain. Brain Res Bull 65:141–148
doi: 10.1016/j.brainresbull.2004.12.007
Ghafouri-Fard S, Eghtedarian R, Hussen BM, Motevaseli E, Arsang-Jang S, Taheri M (2021a) Expression Analysis of VDR-Related LncRNAs in Autism Spectrum Disorder. J Mol Neurosci 71:1403–1409
doi: 10.1007/s12031-021-01858-y
Ghafouri-Fard S, Eghtedarian R, Taheri M, Beatrix Brhul A, Sadeghi-Bahmani D, Brand S (2021b) A Review on the Expression Pattern of Non-coding RNAs in Patients With Schizophrenia: With a Special Focus on Peripheral Blood as a Source of Expression Analysis. Front Psychiatry 12:640463
Gibbons A, Udawela M, Dean B (2018) Non-Coding RNA as Novel Players in the Pathophysiology of Schizophrenia. Non-Coding RNA 4:11
doi: 10.3390/ncrna4020011
Harrison RN, Murray RM, Lee SH, Paya Cano J, Dempster D, Curtis CJ, Dima D, Gaughran F, Breen G, De Jong S (2016) Gene-expression analysis of clozapine treatment in whole blood of patients with psychosis. Psychiatr Genet 26:211–217
doi: 10.1097/YPG.0000000000000140
Jiang YJ, Bikle DD (2014) LncRNA: a new player in 1α, 25(OH)(2) vitamin D(3) /VDR protection against skin cancer formation. Exp Dermatol 23:147–150
doi: 10.1111/exd.12341
Kholghi Oskooei V, Geranpayeh L, Omrani MD, Ghafouri-fard S (2018) Assessment of functional variants and expression of long noncoding RNAs in vitamin D receptor signaling in breast cancer. Cancer Manag Res 10:3451–3462
doi: 10.2147/CMAR.S174244
Li T, Wang B, Zhang L, Cui M, Sun B (2020) Silencing of long noncoding RNA LINC00346 inhibits the tumorigenesis of colorectal cancer through targeting MicroRNA-148b. Onco Targets Ther 13:3247
doi: 10.2147/OTT.S242715
Mazdeh M, Zamani M, Eftekharian MM, Komaki A, Arsang-Jang S, Taheri M, Ghafouri-Fard S (2019) Expression analysis of vitamin D receptor-associated lncRNAs in epileptic patients. Metab Brain Dis 34:1457–1465
doi: 10.1007/s11011-019-00446-9
Mcgrath J (1999) Hypothesis: is low prenatal vitamin D a risk-modifying factor for schizophrenia?. Schizophr Res 40:173–177
doi: 10.1016/S0920-9964(99)00052-3
Mcgrath J, Iwazaki T, Eyles D, Burne T, Cui X, Ko P, Matsumoto I (2008) Protein expression in the nucleus accumbens of rats exposed to developmental vitamin D deficiency. PLoS One 3:e2383
Miyoshi T, Maruhashi M, van de Putte T, Kondoh H, Huylebroeck D, Higashi Y (2006) Complementary expression pattern of Zfhx1 genes Sip1 and deltaEF1 in the mouse embryo and their genetic interaction revealed by compound mutants. Dev Dyn 235:1941–1952
doi: 10.1002/dvdy.20799
Perkins DO, Jeffries CD, Jarskog LF, Thomson JM, Woods K, Newman MA, Parker JS, Jin J, Hammond SM (2007) microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. Genome Biol 8:1–11
doi: 10.1186/gb-2007-8-2-r27
Ravanpay AC, Hansen SJ, Olson JM (2010) Transcriptional inhibition of REST by NeuroD2 during neuronal differentiation. Mol Cell Neurosci 44:178–189
doi: 10.1016/j.mcn.2010.03.006
Ryan JW, Anderson PH, Morris HA (2015) Pleiotropic activities of vitamin D receptors–adequate activation for multiple health outcomes. Clin Biochem Rev 36:53
pubmed: 26224895
pmcid: 4504155
Schoenrock SA, Tarantino LM (2016) Developmental vitamin D deficiency and schizophrenia: the role of animal models. Genes Brain Behav 15:45–61
doi: 10.1111/gbb.12271
Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC (1998) The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59:22–33
pubmed: 9881538
Tong WH, Mu JF, Zhang SP (2020) LINC00346 accelerates the malignant progression of colorectal cancer via competitively binding to miRNA-101-5p/MMP9. Eur Rev Med Pharmacol Sci 24:6639–6646
pubmed: 32633353
Van Den Berg M, Krauskopf J, Ramaekers J, Kleinjans J, Prickaerts J, Briede J (2020) Circulating microRNAs as potential biomarkers for psychiatric and neurodegenerative disorders. Prog neurobiol 185 101732
Xu TP, Ma P, Wang WY, Shuai Y, Wang YF, Yu T, Xia R, Shu YQ (2019) KLF5 and MYC modulated LINC00346 contributes to gastric cancer progression through acting as a competing endogeous RNA and indicates poor outcome. Cell Death Differ 26:2179–2193
doi: 10.1038/s41418-018-0236-y
Zhao X, Liu Y, Li Z, Zheng S, Wang Z, Li W, Bi Z, Li L, Jiang Y, Luo Y, Lin Q, Fu Z, Rufu C (2018) Linc00511 acts as a competing endogenous RNA to regulate VEGFA expression through sponging hsa-miR-29b-3p in pancreatic ductal adenocarcinoma. J Cell Mol Med 22:655–667
doi: 10.1111/jcmm.13351